HST-1 helps manage side-effects of cancer treatment
an antioxidant called resveratrol, found in plants like grapes, peanuts, spruce, lily and mulberries, is known to be a good anticancer agent but it decelerates ulcer healing. Cancer patients are given pain killers that cause ulcers as side-effects. Hence resveratrol cannot be given to cancer patients with gastric ulcers. To do away with this limitation, a research team from Kolkata has synthesized a novel anti-cancer compound that is structurally similar to resveratrol and does not disrupt the ulcer healing process.
A team led by researchers from Kolkata's B C Roy Institute of Basic Medical Sciences and Institute of Post Graduate Medical Education and Research, Anthropological Survey of India and Bio-Organic Division at the Bhabha Atomic Research Centre, Mumbai, synthesized several substances structurally similar to resveratrol. While doing it, they hit upon a novel compound called hst-1. This drug inhibited the growth of two types of human blood cancer cells and didn't have the drawback of resveratrol.
To test the efficacy of hst-1 against ulcers, the researchers fed mice with indomethacin, a non-steroidal anti-inflammatory painkiller, to cause ulcers in their stomachs. These mice then received either resveratrol or hst-1 and were compared with ulcerated untreated mice.
"hst-1 accelerated the healing of the ulcers along with showing strong anticancer properties similar to that of resveratrol," said lead researcher Sandip K Bandyopadhyay. In an ulcerated condition, the activity of the enzyme myeloperoxidase (mpo) increases at the site of inflammation, blocking the healing process. There was a marked reduction in the activity of mpo in hst-1 treated mice compared to the ulcerated untreated and resveratrol-treated mice, confirming its ulcer-healing potency. They found that resveratrol also suppressed the activity of cyclooxygenase-1 (cox-1), an enzyme that aids in the synthesis of prostaglandin E2 which protects the inner lining of the stomach from acid attack. hst-1 did not inhibit the activity of cox-1.
The researchers exposed hst-1 and resveratrol to cultured cells of two types of human blood cancers for two days. When it came to driving the cancer cells to commit mass suicide, hst-1 proved more effective than resveratrol. The study was published in the December 9 issue of Journal of Pharmacology And Experimental Therapeutics.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.